Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Deborah Tweddle

Newcastle AuthorsTitleYearFull text
Professor Deborah Tweddle
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial2026
Angharad Goodman
Professor Deborah Tweddle
Harmonization of Reporting for Detection of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study2026
Nermine Basta
Dr Louise Hayes
Dr Colin Muirhead
Professor Deborah Tweddle
Dr Richard McNally
Temporal clustering of neuroblastic tumours in children and young adults from Scotland2026
Dr Marina Danilenko
Sharanya Nath
Jack Baines
Freya Gordon
Swathi Merugu
et al.		Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA2025
Professor Alastair Greystoke
Professor Deborah Tweddle
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology2025
Professor Deborah Tweddle
Dr Vickyanne Carruthers
Hany Gabra
Management of Ganglioneuroma and Ganglioneuroblastoma Intermixed: A United Kingdom Children's Cancer and Leukaemia Group (UK CCLG) Nationwide Study Report2025
Dr Leigh McDonald
Angharad Goodman
Professor Deborah Tweddle
Spontaneous regression of a greater than 5 cm infant neuroblastoma after a three-fold volume increase without life- or organ-threatening features2025
Professor Steven Clifford
Professor Deborah Tweddle
Dr Quentin Campbell Hewson
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States2025
Dr Anna Basu
Professor Deborah Tweddle
A Case of High Risk Neuroblastoma Presenting after Completion of Treatment for Opsoclonus Myoclonus Ataxia Syndrome2024
Professor Deborah Tweddle
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial2024
Dr Lindi Chen
Professor Deborah Tweddle
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models2023
Dr Shelby Barnett
Professor Deborah Tweddle
Professor Gareth Veal
Generation of evidence-based carboplatin dosing guidelines for neonates and infants2023
Ruby Barford
Fang Fong
Hannah Hartley
Dr Lisa Allinson
Professor Deborah Tweddle
Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma2023
Dr Shelby Barnett
Dr Vickyanne Carruthers
Professor Deborah Tweddle
Professor Gareth Veal
Clinical pharmacology of cytotoxic drugs in neonates and infants: providing evidence-based dosing guidance2022
Wen Hao
Professor Deborah Tweddle
Dr Ed Schwalbe
Dr Gordon Strathdee
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma2022
1234567